Correlation analysis of IL-33 level and multiple myeloma
Niu Shu-l
Abstract
Niu Shu-l
Abstract
Objective To detect serum IL-33 level of multiple myeloma patients,and to explore the correlation between IL-33 level and multiple myeloma. Methods From Jan 2012-Jan 2013,37 cases of multiple myeloma( MM) patients and 50 cases of healthy controls were assigned as the research objects,ELISA method used to detecte serum levels of IL-33 of all the objects. Data were analyzed using method of statistics. Results IL-33 detection rate of two groups had no significant difference,but IL-33 level of MM patients decreased significantly compared with healthy controls( P 0. 05),and IL-33 level of MM had been shown to negatively correlate with MM stage. Conclusions IL-33 levels may be decreased by adjusting the cellular immunity to promote the progress of MM. Maintaining the balance of T cell subgroup may contribute to the treatment of myeloma disease.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To detect serum IL-33 level of multiple myeloma patients,and to explore the correlation between IL-33 level and multiple myeloma. Methods From Jan 2012-Jan 2013,37 cases of multiple myeloma( MM) patients and 50 cases of healthy controls were assigned as the research objects,ELISA method used to detecte serum levels of IL-33 of all the objects. Data were analyzed using method of statistics. Results IL-33 detection rate of two groups had no significant difference,but IL-33 level of MM patients decreased significantly compared with healthy controls( P 0. 05),and IL-33 level of MM had been shown to negatively correlate with MM stage. Conclusions IL-33 levels may be decreased by adjusting the cellular immunity to promote the progress of MM. Maintaining the balance of T cell subgroup may contribute to the treatment of myeloma disease.
Key concepts: Multiple myeloma, Medicine, Correlation, Internal medicine, Gastroenterology, Interleukin 6, Immunity, Significant difference